Lv3
390 积分 2025-03-10 加入
Fibroblast Activation Protein-Targeted Radioligand Therapy with 177Lu-EB-FAPI for Metastatic Radioiodine-Refractory Thyroid Cancer: First-in-Human, Dose-Escalation Study
1个月前
已完结
Feasibility and Therapeutic Potential of 177Lu–Fibroblast Activation Protein Inhibitor–46 for Patients With Relapsed or Refractory Cancers
1个月前
已完结
Safety of Fibroblast Activation Protein–Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI04
1个月前
已完结
Theranostic Potential of [68Ga]Ga/[177Lu]Lu-LNC1013: A Dual-Purpose Ligand for Cancer Imaging and Radionuclide Therapy
1个月前
已完结
High expression of peptide receptors as a novel target in gastrointestinal stromal tumours
2个月前
已完结
Gastrin-Releasing Peptide Receptor Expression in Lung Cancer
2个月前
已完结
Phase 1 Study of [ 177 Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results
2个月前
已完结
Chain-of-Visual-Thought: Teaching VLMs to See and Think Better with Continuous Visual Tokens
2个月前
已完结
CONSORT 2025 Statement
4个月前
已完结
Biodistribution and Radiation Dosimetry of [68Ga]Ga-RAYZ-8009, a Glypican 3–Targeting Compound for Imaging of Hepatocellular Carcinoma
4个月前
已关闭
皖公网安备34019202002308
